Global Novel Drug Delivery Market Size
The market for novel drug delivery systems was valued at US$23.05 billion in 2020 and is projected to grow at a compound annual growth rate of 2.50% to reach US$29.39 billion by 2030.
The regulated release of the medications, which selectively targets the place of action, is the innovative drug delivery technology. To create the perfect medication, novel drug delivery systems are being tried. NDDS avoid the non-diseased tissue while delivering the medications intact to the site of action. Under many physiological conditions, NDDS delivery may be maintained because it is steady. The term "drug delivery" describes the strategies, compositions, production processes, packaging, distribution, and technological aspects of getting a pharmaceutical ingredient to its intended location and achieving the intended therapeutic outcome. It is common knowledge that principles related to drug production, administration route, metabolism, site-specific targeting, and toxicity optimization will maximize safety and efficacy while improving patient convenience and adherence. The goal of medication delivery is to change the pharmacokinetics of medicine and specificity by combining it with other drug carriers, medical equipment, and excipients. To improve therapeutic results, there is more focus on a drug's bioavailability and duration of action. Improving the safety of medicine administration has also been the subject of some studies. For example, various microneedle patches are designed to administer immunizations and other drugs to reduce the risk of needlestick injuries.